Title 45, Title 45: PROFESSIONS AND OCCUPATIONS

45:14-76 Compliance with federal law, standards. 37. Pharmacists and pharmacies shall comply with the provisions of the federal Standards of Practice of Individually Identifiable Health Information, 45 C.F.R. Parts 160 and 164. L.2003,c.280,s.37.

45:14-77 Immunity from civil damages for reports of alleged misconduct. 38. A person who in good faith and without malice provides to the board any information concerning any act by a pharmacist licensed by the board which the person has reasonable cause to believe involves misco…

45:14-78 Currently licensed pharmacists, practice sites. 39. a. Any person who is licensed in this State as a pharmacist on the effective date of this act may continue to practice under his current license until its expiration, and to obtain a license under this act without exami…

45:14-79 Prior regulations unaffected. 40. This act shall not affect the orders, rules and regulations regarding the practice of pharmacy made or promulgated by the board created pursuant to R.S.45:14-1 et seq. prior to the effective date of this act. L.2003,c.280,s.40.

45:14-80 Pharmacy technicians, conditions. 41. a. Pharmacy technicians may assist a licensed pharmacist in performing the following tasks: (1) Retrieval of prescription files, patient files and profiles and other records, as determined by the board, pertaining to the practice of …

45:14-81 "New Jersey Prescription Drug Retail Price Registry." 1. a. There is established the "New Jersey Prescription Drug Retail Price Registry" in the Division of Consumer Affairs in the Department of Law and Public Safety for the purpose of making retail price information for…

45:14-82 Annual list of 150 most frequently prescribed prescription drugs distributed to pharmacies; drug retail price list maintained by pharmacy. 2. a. The Director of the Division of Consumer Affairs shall prepare at least annually, and shall make available to each pharmacy pr…

45:14-82.1 Prescription drug pricing disclosure website. 1. a. As provided in subsection c. of this section, the Division of Consumer Affairs in the Department of Law and Public Safety shall develop a prescription drug pricing disclosure website in order to make prescription drug…

45:14-82.10 Division, prepare, make available, website, report, emerging trends, prescription drug prices; annual public hearing, report findings; confidential information, protect, public disclosure; submit complaints. 9. a. The division shall annually prepare and make available…

45:14-82.11 Drug Affordability Council, established; membership, purpose, duties. 10. a. The Drug Affordability Council is established in, but not of, the Department of Law and Public Safety. The purpose of the council is to formulate legislative and regulatory policy recommendat…

45:14-82.12 Severability. 11. If any provision of this act, P.L.2023, c.106 (C.45:14-82.2 et seq.) or the application thereof to any person or circumstance is held invalid, the invalidity shall not affect other provisions or applications of the sections which can be given effect …

45:14-82.13 Rules, regulations. 12. Notwithstanding the provisions of the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to the contrary, the Director of the Division of Consumer Affairs may adopt, immediately upon filing with the Office of Administrative L…

45:14-82.2 Definitions. 1. As used in P.L.2023, c.106 (C.45:14-82.2 et seq.): "Biosimilar" means a drug that is produced or distributed pursuant to a biologics license application approved under 42 U.S.C. s.262(k)(3). "Brand-name drug" means a prescription drug approved under 21 …

45:14-82.3 Manufacturer, notify, increase, wholesale acquisition cost; parameters. 2. a. A manufacturer shall notify the division if it is increasing the WAC of a brand-name drug by more than 10 percent per pricing unit during any 12-month period, or if it is increasing the WAC o…

45:14-82.4 Pharmacy benefits manager, drug pricing, report, minimum data. 3. a. A pharmacy benefits manager shall, to the extent allowed by law, report to the division the following minimum data, and other data that may be specified by the division. The division shall annually no…

45:14-82.5 Wholesaler, drug pricing, report, minimum data. 4. a. A wholesaler shall report to the division the following minimum data, and other data that may be specified by the division. The division shall annually notify wholesalers of the specific drugs or drug groups for whi…

45:14-82.6 Carrier, reporting entity, drug pricing, report, minimum data. 5. a. A carrier designated by the division as a reporting entity shall report annually to the division, to the extent allowed by law, the spending on prescription drugs before enrollee cost sharing and enro…

45:14-82.7 Pharmacy services administrative organization, drug pricing, report, extent allowed. 6. a. A pharmacy services administrative organization shall, to the extent allowed by law, report annually to the division: (1) the negotiated reimbursement rate that the pharmacy serv…

45:14-82.8 Reporting entity, certify, required; failure, penalties; corrective action plan. 7. a. The reporting entity shall certify required reporting under sections 2 through 6 of P.L.2023, c.106 (C.45:14-82.3 through 45:14-82.7) as accurate under the penalty of perjury. b. Fai…

45:14-82.9 Reporting entity, register, Division of Consumer Affairs, deadline, exceptions; Director, certify actual, prospective costs, Division; requests, payment, final assessments. 8. a. Each reporting entity shall register with the division in a form and manner specified by t…

45:14-83 Definitions. 1. As used in this act: "Board" means the New Jersey State Board of Pharmacy established pursuant to P.L.2003, c.280 (C.45:14-40 et seq.) "Non-prescription diabetes test device" means a glucose meter or test strip for use in the treatment of prediabetic or d…

45:14-84 Authorized distributors. 2. a. A manufacturer of a non-prescription diabetes test device that is distributed within New Jersey shall make the names of its authorized distributors available on its Internet Web site. A manufacturer of a non-prescription diabetes test devic…

45:14-85 Additional responsibilities of board. 3. In addition to the responsibilities given to the board pursuant to the "New Jersey Pharmacy Practice Act," P.L.2003, c.280 (C.45:14-40 et seq.), the board shall require that a pharmacy that dispenses non-prescription diabetes test…

45:14-86 Disciplinary action. 4. A pharmacist who sells, offers for sale, or otherwise dispenses to the public a non-prescription diabetes test device that the pharmacist knows or reasonably should have known was not acquired by the pharmacy either directly from the manufacturer …